![[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!](https://businessfortnight.com/wp-content/uploads/2025/10/Toyota-Times-Century-as-a-Brand-Lexus-as-Innovation-All-218x150.jpg "[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!")
MIAMI BEACH, Fla., Sept. 09, 2022 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology firm centered on the analysis and discovery of latest and efficient remedies for psychiatric and neurological issues, right this moment introduced that its Chief Executive Officer, Dr. Tiago Reis Marques, will ship a digital presentation at the H.C. Wainwright 24th Annual Global Investment Conference, being held from September 12-14, 2022 in New York, as follows:
Date: Monday, September 12, 2022
Time: 7:00AM ET
During the convention Pasithea will probably be taking part in digital 1×1 conferences that may be requested through H.C. Wainwright.
A pre-recorded presentation will probably be made will probably be accessible through the Company’s web site at ir.pasithea.com.
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corporation is a U.S. biotechnology firm centered on the analysis and discovery of latest and efficient remedies for psychiatric and neurological issues. With an skilled workforce of specialists in the fields of neuroscience and psychopharmacology, Pasithea is growing new molecular entities for the therapy of psychiatric and neurological issues. Pasithea can also be centered on addressing the wants of sufferers at the moment struggling with psychological sickness by offering entry to IV ketamine infusions each in clinics and in-home settings.
Pasithea Therapeutics Corp. Company Contact
Dr. Tiago Reis Marques
Chief Executive Officer
E: [email protected]
Pasithea Therapeutics Corp. Investor Relations
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: [email protected]
